Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-102,190
Closed -$5.11M 218
2025
Q4
$5.11M Buy
102,190
+2,491
+2% +$120K 0.78% 47
2025
Q3
$4.89M Buy
99,699
+49,644
+99% +$2.54M 0.77% 48
2025
Q2
$2.59M Buy
50,055
+10,922
+28% +$502K 0.46% 74
2025
Q1
$1.83M Buy
+39,133
New +$2.02M 0.34% 105
2023
Q3
Sell
-35,043
Closed -$1.06M 178
2023
Q2
$1.06M Buy
35,043
+15,261
+77% +$446K 0.26% 90
2023
Q1
$610K Buy
19,782
+1,240
+7% +$47.2K 0.16% 124
2022
Q4
$696K Buy
18,542
+1,217
+7% +$48.3K 0.19% 110
2022
Q3
$650K Buy
17,325
+453
+3% +$18K 0.2% 100
2022
Q2
$608K Buy
16,872
+426
+3% +$17.6K 0.18% 116
2022
Q1
$806K Buy
16,446
+3,288
+25% +$166K 0.2% 107
2021
Q4
$630K Buy
13,158
+560
+4% +$26.5K 0.16% 116
2021
Q3
$553K Buy
12,598
+1,564
+14% +$66.1K 0.15% 118
2021
Q2
$484K Buy
11,034
+1,825
+20% +$85.7K 0.13% 129
2021
Q1
$421K Buy
9,209
+340
+4% +$14.2K 0.13% 132
2020
Q4
$324K Buy
+8,869
New +$257K 0.1% 141

Other funds holding SNV

Oliver Luxxe Assets's SNV Position: Q1 2026 in Review

Oliver Luxxe Assets sold out of Synovus (SNV) in Q1 2026, closing a stake of 102,190 shares — an estimated $5.11M sold.

Oliver Luxxe Assets first reported a position in SNV in Q4 2020 and held it in 15 quarters. The position peaked at $5.11M in Q4 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Oliver Luxxe Assets reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Oliver Luxxe Assets sold 102,190 Synovus shares in Q1 2026, an estimated $5.11M.
  • Oliver Luxxe Assets first reported a position in Synovus in Q4 2020 and held it in 15 quarters.
  • Oliver Luxxe Assets's Synovus position peaked at $5.11M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Oliver Luxxe Assets's 13F filing for Q1 2026, filed 8 Apr 2026.